Community-Based Approach in Vaccine Trials: Insights and Challenges from COVID-19 Vaccine Trials in Nepal

Abstract

Vaccine trials in Nepal are not a new phenomenon. However, following the COVID-19 pandemic, there were several vaccine trials for COVID-19 vaccines in Nepal. Unlike previous trials, COVID-19 vaccine studies required swift and large-scale enrollment from communities. These trials aimed to recruit healthy individuals to evaluate the safety and efficacy of the vaccines in preventing the targeted disease.

In the clinical trials other than vaccine, researchers can enroll patients with specific medical conditions with their consent from the hospital. In contrast, vaccine trials require researchers to recruit healthy volunteers, who are primarily found in community settings. Recruiting healthy individuals from these communities is challenging because it involves navigating various layers of community stakeholders who must be supportive and grant permission for participation. Therefore, community-wide engagement is crucial for vaccine trials.

Communities need to be fully informed and positively engaged, despite potential negative influences from media and misconceptions about the trials. Despite these challenges, effective community interventions and engagement resulted in the successful enrollment of up to 4,600 participants across three trial centers within just two months.

Conducting the clinical trial in Nepal with a community-based approach has been both enriching and effective. This strategy facilitated smooth implementation and deepened connections with the local population. Engaging with community leaders, stakeholders, and members helped overcome challenges such as participant recruitment and adverse event management. The active involvement of community members in various trial stages fostered trust, cooperation, and empowerment. This experience underscored the importance of community engagement, cultural sensitivity, and collaboration in achieving successful and sustainable clinical research.